Monitor for any subsequent conversion to a 13D filing, which would signal a shift from passive to activist intent. The increase in FMR's stake is consistent with its role as a top institutional holder and does not indicate a change in investment thesis.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $21.50entry
- T+1 · 8d ago +5.77%α +3.40% · $22.74
- T+5 · 4d ago +18.60%α +16.01% · $25.50
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026, representing 15.0% of shares outstanding. This is an increase from the prior filing, which did not specify a stake percentage but listed Fidelity Management & Research Company LLC as a 5%+ owner. The filing is a routine passive stake update with no change in investment intent.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 25,286,624 shares of Tango Therapeutics common stock as of October 30, 2026.
- The stake represents 15.0% of the outstanding shares.
- Fidelity Management & Research Company LLC is the entity within FMR that owns 5% or greater of the shares.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- The joint filing agreement was executed on November 5, 2026.
Financial Impact
FMR LLC holds 25,286,624 shares, representing 15.0% of Tango Therapeutics outstanding stock.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002952 |
| Document: 0000315066-26-002952-index-headers.html | 0000315066-26-002952 |
| Document: 0000315066-26-002952-index.html | 0000315066-26-002952 |
| Document: 0000315066-26-002952.txt | 0000315066-26-002952 |
Track record
27 reports on TNGX
3 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +29.28% at T+60 after the Jun 8, 2026 report. 5 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.22 Now $24.17 +0.21% settles Feb 16
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $24.50 Now $24.17 +1.35% settles Feb 12
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $22.74 Now $24.17 +6.29% settles Feb 5
- Nov 6, 202610d ago SC 13G/A Neutral 2/10 Viewing Entry $21.50 Now $24.17 +12.42% settles Feb 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $20.87 Now $24.17 +15.81% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $23.17 Now $24.17 +4.32% settles Feb 1
- Oct 23, 202624d ago 8-K Bullish 7/10 Entry $23.34 Now $24.17 +3.56% settles Jan 21
- Aug 11, 202613w ago 8-K Bearish 6/10 Entry $25.58 to $23.18 Now $24.17 +5.51% ▲ +9.38% +4.51% vs SPY
- Aug 11, 202613w ago 8-K Bullish 7/10 No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers